MICROBIOME SEQUENCING SERVICE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

The requirement for specialized infrastructure and bioinformatics tools poses a significant challenge for the growth of microbiome sequencing service market. Processing and analyzing the vast amounts of data generated through microbiome sequencing requires high computational power and storage. It involves complex techniques like pre-processing of raw sequence reads, alignment to reference databases, taxonomy assignment, phylogenetic and functional analysis. Performing these steps demand clustering computing systems, high-bandwidth networks, huge storage arrays and advanced analytics software capable of handling petabytes of genomic and metabolic information. Setting up such a robust bioinformatics pipeline requires tremendous investment of capital and resources. This acts as a major deterrent for smaller labs and research institutions to offer microbiome sequencing as a service.

Market Opportunity – Targeted Drug Discovery based on Human and Environmental Microbiome Insights

Targeted drug discovery based on human and environmental microbiome insights can provide great opportunities in the microbiome sequencing service market. The human microbiome, which consists of trillions of microbes playing an important role in health, is an untapped source for the discovery of novel drugs, disease biomarkers and probiotics. Sequencing the microbiome communities inhabiting body, coupled with meta-omics analysis, can help gain in-depth insights about the microbes and their role in various diseases. This knowledge can further aid in developing precision diagnostics and therapeutics. For example, microbiome-based research has linked altered gut bacteria with various diseases like diabetes, obesity, cancer etc. and led to identification of potential drug targets and probiotics.